M
Maciej Kempa
Researcher at Gdańsk Medical University
Publications - 88
Citations - 553
Maciej Kempa is an academic researcher from Gdańsk Medical University. The author has contributed to research in topics: Implantable cardioverter-defibrillator & Medicine. The author has an hindex of 10, co-authored 74 publications receiving 493 citations.
Papers
More filters
Journal ArticleDOI
New insight into repolarization abnormalities in patients with congenital long qt syndrome : the increased transmural dispersion of repolarization
TL;DR: The transmtiral dispersion of repolarization in LQTS patients was assessed using Holter system and spatial QT dispersion was measured from 12 lead ECG and 3 channel Holter tape as a difference between the shortest and the longest QT interval between leads.
Journal ArticleDOI
The Terminal Portion of the T Wave: A New Electrocardiographic Marker of Risk of Ventricular Arrhythmias
A. Lubinski,Kornacewicz-Jach Z,Wnuk-Wojnar Am,Adamus J,Maciej Kempa,Tomasz Królak,Ewa Lewicka-Nowak,Radomski M,G. Swiatecka +8 more
TL;DR: The hypothesis that TpTe reflects transmural dispersion of repolarization is supported and may serve as a marker of risk of ventricular arrhythmias in patients with coronary artery disease and survivors of myocardial infarction.
Journal ArticleDOI
Implantation and follow-up of ICD leads implanted in the right ventricular outflow tract.
A. Lubinski,Ewa Lewicka-Nowak,Tomasz Królak,Maciej Kempa,Beata Bielawska,Rajmund Wilczek,G. Swiatecka +6 more
TL;DR: There was no further dislodgment of RVOT defibrillation leads or other lead related complications during a follow-up of 23 ± 9 months, and active‐fixation ICD leads should be considered to limit the risk of electrode dislodgement.
Journal Article
Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators.
Andrzej Lubiński,Ewa Lewicka-Nowak,Agnieszka Zienciuk,Tomasz Królak,Maciej Kempa,Anna Pazdyga,G. Swiatecka +6 more
TL;DR: Tall stature, enhanced LVEDD, decreased LVEF and amiodarone therapy increase the risk of a high DFT in ICD recipients, and chronic amiodARone therapy increases three times therisk of elevated DFT.
Journal ArticleDOI
Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey.
Serge Boveda,Radosław Lenarczyk,Stefano Fumagalli,Roland Tilz,Kinga Goscinska-Bis,Maciej Kempa,Pascal Defaye,Christelle Marquié,Alessandro Capucci,Laura Ueberham,Nikolaos Dagres +10 more
TL;DR: The purpose of this European Heart Rhythm Association (EHRA) prospective snapshot survey is to provide an overview of the factors influencing patient selection for the implantation of a particular type of device: subcutaneous implantable cardioverter-defibrillator (S-ICD) or transvenous implantableCardiac resynchronisation therapy (CRT) or back-up defibrillators (TV-ICd) across a broad range of tertiary European centres.